CC
QTTB icon

Cannell Capital’s Q32 Bio QTTB Stock Holding History

Cannell Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,220
Closed -$22.6K – 86
2023
Q1 		$22.6K Hold
1,220
– – ﹤0.01% 85
2022
Q4 		$27.7K Hold
1,220
– – 0.01% 84
2022
Q3 		$35K Buy
1,220
+900
+281% +$36.7K 0.01% 85
2022
Q2 		$11K Buy
+320
New +$10.9K ﹤0.01% 82

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell Capital's QTTB Position: Q2 2023 in Review

Cannell Capital sold out of Q32 Bio (QTTB) in Q2 2023, closing a stake of 1,220 shares — an estimated $22.6K sold.

Cannell Capital first reported a position in QTTB in Q2 2022 and held it in 4 quarters. The position peaked at $35K in Q3 2022. 59 funds tracked by Wall St. Rank hold QTTB as of Q2 2023.

  • Cannell Capital reported no remaining Q32 Bio position as of Q2 2023 after selling out during the quarter.
  • Cannell Capital sold 1,220 Q32 Bio shares in Q2 2023, an estimated $22.6K.
  • Cannell Capital first reported a position in Q32 Bio in Q2 2022 and held it in 4 quarters.
  • Cannell Capital's Q32 Bio position peaked at $35K in Q3 2022.
  • 59 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2023.

Based on Cannell Capital's 13F filing for Q2 2023, filed 14 Aug 2023.